Vairavan Latha — SEC Form 4 filings
SEC reporting owner CIK 2065881. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-13.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2025-05-07 to 2026-05-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 6,126 shares, $149,771 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 2,772 shares @ $25.16 ($69,745) in Arcutis Biotherapeutics, Inc., filed 2026-03-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | SVP Chief Financial Officer | 7 | — | 7 legs · 6,126 sh · $149,771 | 4 |
Form 4 filings — Vairavan Latha
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-13 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 435 @ $21.05 | EDGAR |
| 2026-05-06 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 1,341 @ $23.61 | EDGAR |
| 2026-03-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 27,000 @ $0 · Sale (S): 2,772 @ $25.16 · Sale (S): 81 @ $25.91 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 1,320 @ $25.50 | EDGAR |
| 2025-11-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 88 @ $24.72 | EDGAR |
| 2025-08-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 89 @ $14.33 | EDGAR |
| 2025-05-07 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 20,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2065881 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →